ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Comparison of Outcomes From Sequential Endoscopic Therapy in 60 Patients With Cirrhosis and Esophagogastric Varices Treated at a Provincial and a Tertiary District Hospital.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND This retrospective study aimed to compare outcomes from sequential endoscopic therapy using a planned, multi-stage eradication approach with combined endoscopic techniques in 60 patients with cirrhosis and esophagogastric varices (EGV) treated at a provincial and a tertiary district hospital. MATERIAL AND METHODS Patients receiving secondary prophylaxis of EGV at Pidu District People's Hospital (district tertiary hospital, group A) and Sichuan Provincial People's Hospital (provincial tertiary hospital, group B) between June 1, 2022, and June 30, 2024, were retrospectively included. Group B exhibited more severe baseline disease, including larger portal vein and spleen sizes. Follow-ups at 1, 3, 6, and 12 months assessed clinical symptoms, efficacy, treatment modalities, complications, and compliance. RESULTS A total of 60 patients were included, with 30 in group A and 30 in group B. Both groups achieved significant 12-month endoscopic improvements. Severe EGV decreased markedly in group A (73.33% to 6.67%) and group B (83.33% to 20.00%). The red color sign (Rc+) prevalence decreased in group A (96.43% to 11.11%) and group B (93.10% to 34.78%). Group B exhibited reduced mean variceal diameter (1.03 to 0.40 cm) and decreased ascites. Despite differences in specific endoscopic approaches and patient follow-up adherence, the 12-month incidence of major complications was comparable between groups. CONCLUSIONS Sequential endoscopic therapy demonstrated comparable efficacy and safety in both settings, supporting the safe decentralization of EGV management. However, notable disparities in treatment modality and compliance were observed; thus, future initiatives should prioritize unifying technical training and enhancing patient adherence systems to optimize long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.